XIST and cervical squamous cell carcinoma: These findings demonstrated that XIST could serve as a potential prognostic biomarker in human cancers of gastric cancer, hepatocellular carcinoma, nasopharyngeal carcinoma, pancreatic cancer, osteosarcoma, esophageal squamous cell carcinoma and cervical squamous cell carcinoma.